Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo
Life Science Alliance · 2026
DOI: 10.26508/lsa.202603852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Claudia Hollmann und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Macrophages, Longevity, Anti-Infective Agents. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, HHS | NIH | NIH Office of the Director.
Abstract (Originalsprache)
Multiple immune mechanisms must be coordinated to defend against a broad range of pathogens; however, the mechanisms by which broad-spectrum antipathogens act remain largely elusive. Here, we used systems biology approaches to understand the organization of human immune cells at the single-cell level and their reorganization in response to K21, a silane derivative effective against viral, bacterial, and fungal infections. K21 effectively reduced the infectivity of Enterococcus faecalis within macrophages while improving bacterial phagocytosis by human monocyte–derived macrophages, in a manner similar to that of known mitophagy inducers. K21 induced pro-inflammatory pathways in M1 and M2 macrophages without altering cytokine secretion, decreased a specific subtype of M1 macrophages and M2c macrophages, and improved mitochondrial health by enhancing mitochondrial recycling via mitophagy. Similar treatment of the model organism C. elegans induced mitophagy and extended lifespan, suggesting an evolutionarily conserved mechanism. Our work demonstrates that a drug that remodels mitochondrial metabolism can reshape the immune cell repertoire, potentially aiding the development of more effective antimicrobials and helping to prevent the emergence of drug-resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
- The Waksman Institute, Rutgers The State University of New Jersey, Piscataway, NJ, USA.
- Institute of Microbiology and Virology, Riga Stradiņš University, Riga, Latvia.
- The Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
- ModOmics Ltd, Southampton, UK.
- AccuraScience, Johnston, IA, USA.
ORCID-Profile: Claudia Hollmann, Eun Chan Park, Emīls Edgars Bašēns, Zaiga Nora-Krukle, Mohamed M Elashiry, Christopher Rongo, Bhupesh K Prusty
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- HHS | NIH | NIH Office of the Director
- Amar Foundation, USA
- FiteBac
Zitieren
APA
Hollmann, C., Chan Park, E., Liu, Z., Nourollahi, F., Bašēns, E. E., Dietz, J., Waghmare, T. S., Vora, M., Nikolayshvili, G., Kane, N. S., Li, T., Imdahl, F., Macleod, K. F., Nora-Krukle, Z., Elashiry, M. M., Rongo, C., & Prusty, B. K. (2026). Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo. Life Science Alliance. https://doi.org/10.26508/lsa.202603852
Vancouver
Hollmann C, Chan Park E, Liu Z, Nourollahi F, Bašēns EE, Dietz J, et al. Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo. Life Science Alliance. 2026. doi:10.26508/lsa.202603852
BibTeX
@article{Hollmann2026,
author = {Hollmann, Claudia and Chan Park, Eun and Liu, Zheng and Nourollahi, Faye and Bašēns, Emīls Edgars and Dietz, Jonathan and Waghmare, Trushnal S and Vora, Mehul and Nikolayshvili, Georgy and Kane, Nanci S and Li, Tongbin and Imdahl, Fabian and Macleod, Kay F and Nora-Krukle, Zaiga and Elashiry, Mohamed M and Rongo, Christopher and Prusty, Bhupesh K},
title = {Drug-induced metabolic remodeling promotes antimicrobial activity in macrophages and extends longevity in vivo},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202603852}
}
EUVIMED